NewAmsterdam Cash from 2010 to 2024
| NAMS Stock | 20.84 0.21 1.00% |
Cash | First Reported 2010-12-31 | Previous Quarter 340.4 M | Current Value 231 M | Quarterly Volatility 140.7 M |
Check NewAmsterdam Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewAmsterdam Pharma's main balance sheet or income statement drivers, such as Tax Provision of 28.4 K, Net Interest Income of 3.6 M or Interest Income of 11.8 M, as well as many indicators such as Price To Sales Ratio of 68.31, Dividend Yield of 0.0 or PTB Ratio of 3.02. NewAmsterdam financial statements analysis is a perfect complement when working with NewAmsterdam Pharma Valuation or Volatility modules.
NewAmsterdam | Cash |
Latest NewAmsterdam Pharma's Cash Growth Pattern
Below is the plot of the Cash of NewAmsterdam Pharma over the last few years. Cash refers to the most liquid asset of NewAmsterdam Pharma, which is listed under current asset account on NewAmsterdam Pharma balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from NewAmsterdam Pharma customers. The amounts must be unrestricted with restricted cash listed in a different NewAmsterdam Pharma account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. NewAmsterdam Pharma's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NewAmsterdam Pharma's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
NewAmsterdam Cash Regression Statistics
| Arithmetic Mean | 76,634,292 | |
| Geometric Mean | 18,801,544 | |
| Coefficient Of Variation | 183.54 | |
| Mean Deviation | 104,006,467 | |
| Median | 7,861,000 | |
| Standard Deviation | 140,652,944 | |
| Sample Variance | 19783.3T | |
| Range | 430.7M | |
| R-Value | 0.67 | |
| Mean Square Error | 11769.1T | |
| R-Squared | 0.45 | |
| Significance | 0.01 | |
| Slope | 21,041,399 | |
| Total Sum of Squares | 276965.5T |
NewAmsterdam Cash History
Other Fundumenentals of NewAmsterdam Pharma
NewAmsterdam Pharma Cash component correlations
Click cells to compare fundamentals
About NewAmsterdam Pharma Financial Statements
NewAmsterdam Pharma shareholders use historical fundamental indicators, such as Cash, to determine how well the company is positioned to perform in the future. Although NewAmsterdam Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in NewAmsterdam Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on NewAmsterdam Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash | 340.4 M | 231 M | |
| Cash And Short Term Investments | 340.4 M | 231 M | |
| Change In Cash | -127.3 M | -120.9 M | |
| Free Cash Flow | -141.2 M | -134.2 M | |
| Begin Period Cash Flow | 467.7 M | 491.1 M | |
| Total Cashflows From Investing Activities | -18 K | -18.9 K | |
| Other Cashflows From Financing Activities | 8.9 M | 9.4 M | |
| Other Non Cash Items | 19 M | 24.7 M | |
| Total Cash From Operating Activities | -141.2 M | -134.2 M | |
| Total Cash From Financing Activities | 8.9 M | 8.5 M | |
| End Period Cash Flow | 340.4 M | 231 M | |
| Free Cash Flow Yield | (0.17) | (0.18) | |
| Operating Cash Flow Per Share | (1.72) | (1.63) | |
| Free Cash Flow Per Share | (1.72) | (1.63) | |
| Cash Per Share | 4.14 | 6.14 | |
| EV To Operating Cash Flow | (3.47) | (3.64) | |
| EV To Free Cash Flow | (3.47) | (3.64) | |
| Price To Operating Cash Flows Ratio | (5.88) | (5.59) | |
| Price To Free Cash Flows Ratio | (5.88) | (5.58) | |
| Cash Ratio | 6.82 | 5.03 | |
| Operating Cash Flow Sales Ratio | (11.06) | (11.62) | |
| Free Cash Flow Operating Cash Flow Ratio | 1.00 | 1.10 | |
| Cash Flow Coverage Ratios | (35.65) | (33.87) | |
| Price Cash Flow Ratio | (5.88) | (5.59) | |
| Cash Flow To Debt Ratio | (35.65) | (33.87) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.